Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telcagepant for Prevention of Menstrually Related Migraine
NCT01125774Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of telcagepant in migraine, sponsored by Merck & Co.. Started Jun 2010; status: completed.
02
Drugs
telcagepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01125774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01125774.